Actinogen Medical's market value is the price at which a share of Actinogen Medical trades on a public exchange. It measures the collective expectations of Actinogen Medical Limited investors about its performance. Actinogen Medical is trading at 0.0311 as of the 16th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0311. With this module, you can estimate the performance of a buy and hold strategy of Actinogen Medical Limited and determine expected loss or profit from investing in Actinogen Medical over a given investment horizon. Check out Actinogen Medical Correlation, Actinogen Medical Volatility and Actinogen Medical Performance module to complement your research on Actinogen Medical.
Understanding that Actinogen Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Actinogen Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Actinogen Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Actinogen Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Actinogen Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Actinogen Medical.
0.00
11/18/2025
No Change 0.00
0.0
In 3 months and 1 day
02/16/2026
0.00
If you would invest 0.00 in Actinogen Medical on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Actinogen Medical Limited or generate 0.0% return on investment in Actinogen Medical over 90 days. Actinogen Medical is related to or competes with Vicapsys Life, Zivo Bioscience, Biostem Technologies, Relief Therapeutics, and Helix BioPharma. Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic ... More
Actinogen Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Actinogen Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Actinogen Medical Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Actinogen Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Actinogen Medical's standard deviation. In reality, there are many statistical measures that can use Actinogen Medical historical prices to predict the future Actinogen Medical's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Actinogen Medical. Your research has to be compared to or analyzed against Actinogen Medical's peers to derive any actionable benefits. When done correctly, Actinogen Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Actinogen Medical.
Actinogen Medical February 16, 2026 Technical Indicators
Actinogen Medical secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Actinogen Medical Limited exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Actinogen Medical's Standard Deviation of 7.92, risk adjusted performance of 0.0673, and Mean Deviation of 1.8 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.06, which signifies a somewhat significant risk relative to the market. Actinogen Medical returns are very sensitive to returns on the market. As the market goes up or down, Actinogen Medical is expected to follow. At this point, Actinogen Medical has a negative expected return of -0.35%. Please make sure to confirm Actinogen Medical's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Actinogen Medical performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
Actinogen Medical Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Actinogen Medical time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Actinogen Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Actinogen Medical price fluctuation can be explain by its past prices.
Other Information on Investing in Actinogen Pink Sheet
Actinogen Medical financial ratios help investors to determine whether Actinogen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Actinogen with respect to the benefits of owning Actinogen Medical security.